Inventor · disambiguated record
Cindy T. Dickerson
Also filed as: DICKERSON CINDY T · DICKERSON CINDY TAKEUCHI
7 granted patents·9 pending applications·43 citations·filing 2009–2025
83Inventor score
Top patents by PatentIndex Score
16 records- 0195US11440954B2Optimized anti-TL1A antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Sep 13, 2022·7 cites·20 claims
- 0295US11292848B2Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Apr 5, 2022·14 cites·20 claims
- 0395US10689439B2Optimized anti-TL1A antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2019·Granted Jun 23, 2020·18 cites·18 claims
- 0492US11999789B2Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2022·Granted Jun 4, 2024·2 cites·7 claims
- 0585US2024368263A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0678US7892546B2Anti-CXCR4 antibodiesLILLY CO ELI·Filed 2009·Granted Feb 22, 2011·2 cites·10 claims
- 0778US2023192835A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0878US2024327532A1Humanized antibodies to tnf-like ligand 1a (tl1a) and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0967US2021070871A1Optimized anti-tl1a antibodiesPROMETHEUS BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1062US12305236B2Methods and systems for selection and treatment of patients with inflammatory diseasesCEDARS SINAI MEDICAL CENTER·Filed 2019·Granted May 20, 2025·0 cites·8 claims
- 1162US2025290143A1Methods and systems for selection and treatment of patients with inflammatory diseasesCEDARS SINAI MEDICAL CENTER·Filed 2025·Application pending·0 cites
- 1262US2025340660A1Anti-cd30l antibodies, formulations therefor, and uses thereofPROMETHEUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1362US2023272098A1Methods, systems, and kits for treatment of inflammatory diseases targeting tl1aPROMETHEUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1457US8003102B2Anti-CXCR4 antibodiesLILLY CO ELI·Filed 2010·Granted Aug 23, 2011·0 cites·2 claims
- 1540US2015152172A1Compositions and methods for binding cysteinyl leukotrienes (cyslts) for treatment of diseaseLPATH INC·Filed 2014·Application pending·0 cites
- 1633US2016060328A1Compositions and methods for binding cysteinyl leukotrienes (cyslts) for treatment of diseaseLPATH INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →